NCT06258447View on ClinicalTrials.gov

CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2029

Conditions
Ischemic Heart Failure
Interventions
DEVICE

Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system

the ABM MNC is obtained from the study patient via bone marrow aspiration in the hip and processed and delivered using the CardiAMP cell therapy system during the cardiac catheterization.

Trial Locations (5)

30322

RECRUITING

Emory University, Atlanta

33756

RECRUITING

Morton Plant Hospital - BayCare, Clearwater

44195

NOT_YET_RECRUITING

Cleveland Clinic, Cleveland

48202

RECRUITING

Henry Ford Hospital, Detroit

53792

RECRUITING

University of Wisconsin-Division of Cardiovascular Medicine, Madison

Sponsors

Lead Sponsor

BioCardia, Inc.
All Listed Sponsors
lead

BioCardia, Inc.

INDUSTRY